PRPO – Precipio Inc
Precipio, Inc.PRPO
$11.20Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $16,934,512.00
EPSttm : -2.06
Precipio, Inc.
$11.20
1.50%$0.17Float Short %
1.87
Margin Of Safety %
-48
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
6.25
Price
11.76
Target Price
19
Analyst Recom
1
Performance Q
67.16
Relative Volume
0.77
Beta
1.24
Ticker: PRPO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | PRPO | 6.4528 | N/A | N/A | 0 |
| 2025-05-09 | PRPO | 6.63 | N/A | N/A | 0 |
| 2025-05-12 | PRPO | 6.29 | N/A | N/A | 0 |
| 2025-05-13 | PRPO | 7.08 | N/A | N/A | 0 |
| 2025-05-14 | PRPO | 7.35 | N/A | N/A | 0 |
| 2025-05-15 | PRPO | 7.741 | N/A | N/A | 0 |
| 2025-05-16 | PRPO | 7.88 | N/A | N/A | 0 |
| 2025-05-19 | PRPO | 8.37 | N/A | N/A | 0 |
| 2025-05-20 | PRPO | 8.9664 | N/A | N/A | 0 |
| 2025-05-21 | PRPO | 9.85 | N/A | N/A | 0 |
| 2025-05-22 | PRPO | 9.7 | N/A | N/A | 0 |
| 2025-05-23 | PRPO | 9.68 | N/A | N/A | 0 |
| 2025-05-27 | PRPO | 10.15 | N/A | N/A | 0 |
| 2025-05-28 | PRPO | 9.62 | N/A | N/A | 0 |
| 2025-05-29 | PRPO | 9.96 | N/A | N/A | 0 |
| 2025-05-30 | PRPO | 9.44 | N/A | N/A | 0 |
| 2025-06-02 | PRPO | 10.81 | N/A | N/A | 0 |
| 2025-06-03 | PRPO | 10.93 | N/A | N/A | 0 |
| 2025-06-04 | PRPO | 10.53 | N/A | N/A | 0 |
| 2025-06-05 | PRPO | 11.37 | N/A | N/A | 0 |
| 2025-06-06 | PRPO | 11.46 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | PRPO | 6.29 | - | - | -6.25 |
| 2025-05-09 | PRPO | 6.63 | - | - | -6.25 |
| 2025-05-12 | PRPO | 6.29 | - | - | -6.25 |
| 2025-05-13 | PRPO | 7.00 | - | - | -6.25 |
| 2025-05-14 | PRPO | 7.35 | - | - | -6.25 |
| 2025-05-15 | PRPO | 7.12 | - | - | -6.25 |
| 2025-05-16 | PRPO | 8.35 | - | - | -6.25 |
| 2025-05-19 | PRPO | 8.37 | - | - | -6.25 |
| 2025-05-20 | PRPO | 8.98 | - | - | -6.25 |
| 2025-05-21 | PRPO | 9.50 | - | - | -6.25 |
| 2025-05-22 | PRPO | 9.20 | - | - | -6.25 |
| 2025-05-23 | PRPO | 9.16 | - | - | -6.25 |
| 2025-05-27 | PRPO | 10.04 | - | - | -6.25 |
| 2025-05-28 | PRPO | 9.65 | - | - | -6.25 |
| 2025-05-29 | PRPO | 9.96 | - | - | -6.25 |
| 2025-05-30 | PRPO | 9.44 | - | - | -6.25 |
| 2025-06-02 | PRPO | 10.98 | - | - | -6.25 |
| 2025-06-03 | PRPO | 10.62 | - | - | -6.25 |
| 2025-06-04 | PRPO | 10.70 | - | - | -6.25 |
| 2025-06-05 | PRPO | 11.37 | - | - | -6.25 |
| 2025-06-06 | PRPO | 11.76 | - | - | -6.25 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | PRPO | 0.49 | 14.63 | 1.57 |
| 2025-05-09 | PRPO | 0.49 | 14.63 | 1.57 |
| 2025-05-12 | PRPO | 0.49 | 63.40 | 1.89 |
| 2025-05-13 | PRPO | 1.41 | 63.40 | 1.89 |
| 2025-05-14 | PRPO | 1.41 | 63.40 | 1.89 |
| 2025-05-15 | PRPO | 1.41 | 63.40 | 1.89 |
| 2025-05-16 | PRPO | 1.41 | 63.40 | 1.89 |
| 2025-05-19 | PRPO | 1.42 | 71.77 | 1.89 |
| 2025-05-20 | PRPO | 1.42 | 71.77 | 1.89 |
| 2025-05-21 | PRPO | 3.78 | 71.77 | 1.89 |
| 2025-05-22 | PRPO | 3.78 | 71.77 | 1.89 |
| 2025-05-23 | PRPO | 7.86 | 71.77 | 1.89 |
| 2025-05-27 | PRPO | 8.12 | 51.66 | 1.97 |
| 2025-05-28 | PRPO | 6.59 | 51.66 | 1.93 |
| 2025-05-29 | PRPO | 6.74 | 51.66 | 1.92 |
| 2025-05-30 | PRPO | 7.35 | 51.66 | 1.92 |
| 2025-06-02 | PRPO | 7.35 | 50.61 | 1.92 |
| 2025-06-03 | PRPO | 7.34 | 50.61 | 1.92 |
| 2025-06-04 | PRPO | 7.33 | 50.61 | 1.92 |
| 2025-06-05 | PRPO | 8.46 | 50.61 | 1.87 |
| 2025-06-06 | PRPO | 8.46 | 50.61 | 1.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
-0.93
Avg. EPS Est. Next Quarter
Insider Transactions
8.46
Institutional Transactions
50.61
Beta
1.24
Average Sales Estimate Current Quarter
4
Average Sales Estimate Next Quarter
Fair Value
6.06
Quality Score
43
Growth Score
56
Sentiment Score
93
Actual DrawDown %
93.6
Max Drawdown 5-Year %
-96.8
Target Price
19
P/E
Forward P/E
PEG
P/S
0.85
P/B
1.44
P/Free Cash Flow
24.19
EPS
-2.09
Average EPS Est. Cur. Y
-6.25
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-15.45
Relative Volume
0.77
Return on Equity vs Sector %
-50.5
Return on Equity vs Industry %
-37.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading